In 10 seconds? Bi-specific T cell engagers, or BiTEs, are cutting-edge cancer treatments that are having success in treating some types of blood cancers. Exciting new data on next-generation formulations of these treatments show t...
In 10 seconds? Lymphoma patients with healthy levels of vitamin D seem to respond better to cancer treatments than those with below healthy levels. If results like these hold up in larger studies, it will mean that cancer patients...
In 10 seconds? The Epstein-Barr virus (EBV) causes about 1.5% of all human cancers. Almost everyone is infected with EBV, but due to a wide range of interplaying environmental and genetic factors, only a small percentage develop E...